Great Debates & Updates in Thoracic Malignancies

, San Francisco, California

Pozvání na událost

Témata: Is it time for a new taxane?; Maintenance therapy; Screen everyone for EGFR mutations?; Appropriate setting for EGFR TKIs; EGFR TKI’s – only for mutation patients?; Surgery for stage IIIa patients with lung cancer; Is two cycles of chemoradiation enough?

Registrace

  • Zlevněná registrace do 14. března 2011
  • Běžná registrace do 28. dubna 2011
  • Online registrace

Saturday, May 7, 2011
Moderator: Ramaswamy Govindan, MD

8:00 am
Welcome and introduction
Ramaswamy Govindan, MD

8:05 am
Is it time for a new taxane?

Yes
Suresh S. Ramalingam, MD

No
Primo Lara, MD

8:50 am
Maintenance therapy

Yes
Alan B. Sandler, MD

No
Speaker invited

9:35 am
Screen everyone with metastatic NSCLC for EGFR mutations?

Yes
Anne S. Tsao, MD

No
Heather A. Wakelee, MD

10:20 am
Break

10:40 am
Appropriate setting for EGFR TKIs Frontline/maintenance
Alan B. Sandler, MD

Second line and beyond
Suresh S. Ramalingam, MD

11:25 am
EGFR TKIs Only for mutation patients
Primo Lara, MD

No, for everyone
Karen L. Kelly, MD

12:10 pm
Lunch

1:00 pm
Surgery for stage IIIa patients with lung cancer

Sometimes
Anne S. Tsao, MD

Never
Speaker invited

1:45 pm
Two cycles of chemoradiation 2 cycles is enough
Heather A. Wakelee, MD

2 cycles is not enough
Karen L. Kelly, MD

2:30
Closing notes and adjourn

Více na: http://www.imedex.com/AppWeb/announcements/a254-01.asp  nebo http://www.linkos.cz/odbornici/kongresy/vypisAkce.php?podminka=4&ID=1696

  • Přidat do kalendáře: 2011-05-07 00:00:00 2011-05-07 23:59:59 Europe/Prague Great Debates & Updates in Thoracic Malignancies Témata: Is it time for a new taxane?; Maintenance therapy; Screen everyone for EGFR mutations?; Appropriate setting for EGFR TKIs; EGFR TKI’s – only for mutation patients?; Surgery for stage IIIa patients with lung cancer; Is two cycles of chemoradiation enough? San Francisco, California